News - Page 5 - Psychedelic Alpha

Read more about the article 2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

Post published:January 31, 2025
Post category:Analysis News Pα+

Read more about the article The Psychedelic News Feed: September 2, 2024 – December 29, 2024

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Post published:January 30, 2025
Post category:Psychedelic News Feed Archive

Read more about the article Psychedelic Drug Development Pipeline Updates (Q1’25)

Psychedelic Drug Development Pipeline Updates (Q1’25)

Post published:January 30, 2025
Post category:2024 Year in Review Analysis News Pα+

Read more about the article Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

Post published:January 30, 2025
Post category:2024 Year in Review Analysis

Read more about the article Pα+ Psychedelic Bulletin #186: As Trump Takes Office, Impact on Psychedelics Field Remains Unclear; The Jurvetsons Discuss Psychedelics at DLD; GH Shares PoC Data

Pα+ Psychedelic Bulletin #186: As Trump Takes Office, Impact on Psychedelics Field Remains Unclear; The Jurvetsons Discuss Psychedelics at DLD; GH Shares PoC Data

Post published:January 24, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article Bifurcation Squared: Compass Lobbies for Narrow Rescheduling in Colorado, Virginia; Pushes Back on State Policy Reforms

Bifurcation Squared: Compass Lobbies for Narrow Rescheduling in Colorado, Virginia; Pushes Back on State Policy Reforms

Post published:January 23, 2025
Post category:Analysis News

Read more about the article Psychedelics in 2024: From Hype to Hard Realities

Psychedelics in 2024: From Hype to Hard Realities

Post published:January 21, 2025
Post category:2024 Year in Review Analysis News

Read more about the article mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

Post published:January 17, 2025
Post category:Interviews Pα+

Read more about the article Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected

Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected

Post published:January 16, 2025
Post category:Psychedelic Patent Analysis Pα+

Read more about the article PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted Therapies

PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted Therapies

Post published:January 14, 2025
Post category:Analysis News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.